期刊文献+

双磷酸盐相关性颌骨坏死的循证治疗:附3例报道 被引量:7

Evidence-based diagnosis and treatment of bisphosphonate related osteonecrosis: report of 3 cases
下载PDF
导出
摘要 目的:探讨双磷酸盐相关性颌骨坏死的循证治疗。方法:针对3例双磷酸盐用药患者出现的拔牙创不愈、牙周肿痛、溢脓等症状,提出临床问题,检索收集并评价相关证据,帮助制订治疗方案。结果:共纳入相关文献39篇,结果显示①双磷酸盐相关性颌骨坏死的致病机制不明:诊断标准普遍参照美国口腔颌面外科医师协会的临床指南。②治疗方案为早期有骨坏死或暴露而无明显感染时.先行抗感染、镇痛等非手术治疗:感染症状复发时,行局部清创术;出现大段骨坏死或病理性骨折时.行大范围骨切除。③组织病理学诊断标准尚未建立;影像学检查有助于早期诊断和牙槽骨手术前评估。④停药并不能缓解症状和进程.但在清创和牙槽骨手术期间有利于伤1:3愈合,是否停药由医患双方协商确定。根据以上证据.对3例患者先行保守治疗,效果不佳后行局部清创术,随访6~12个月,疗效良好。结论:双磷酸盐相关性颌骨坏死是近年新出现的疾病。目前致病机制不明,诊断和治疗方法未统一。循证治疗可制定合理方案.有效提高治疗效果和生存质量。 PURPOSE: To explore the diagnosis and treatment of bisphosphonate-related osteonecrosis of the jaw (BONJ) from the view of evidence based medicine. METHODS: For the symptoms of three patients with BONJ, including persisting socket, sore gums, fistula and pyorrhea, the clinical questions were raised, the relative evidences were collected and critically assessed. RRSULTS: Thirty-nine related references were included. The evidences indicated that ①The precise pathogenesis of BONJ remains unknown. The diagnostic criteria proposed by the American Association of Oral and Maxillofacial Surgeons is used widely. ②Non-surgical management is recommended at early stage when there is exposed or necrotic bone without obvious infection symptoms, including antibiotic therapy and pain control, etc. Local debridement is adopted when the infection is uncontrolled or recurrent. Resection of bone beyond the alveolus is performed where there is large segment of necrotic bone or pathological fracture. ③Diagnostic histopathological characteristics of BONJ have yet to be established. Radiographic images can help diagnosing early and assessing the risk before alveolar surgery. ④ Discontinuation of BP therapy can not relieve the symptoms but may be good for wound healing after alveolar surgery, which should be done in consultation with the physician and patient. Based on the available evidence, individualized treatment plans were developed. After a invalid conservative treatment, local debridement was performed and proved to be effective during follow-up. CONCLUSION: As a new disease, the exact mechanism of BONJ has not been completely elucidated.There is currently no consensus on the diagnostic criteria and the best way of trerapy. The treatment efficacy has been improved by determining an individualized treatment according to evidence-based approach.
出处 《中国口腔颌面外科杂志》 CAS 2013年第3期221-228,共8页 China Journal of Oral and Maxillofacial Surgery
基金 湖北省十堰市科学技术研究与开发项目~~
关键词 颌骨坏死 双磷酸盐 双磷酸盐相关性颌骨坏死 循证治疗 Bisphosphonate Bisphosphonate related osteonecrosis of the jaw Evidence-based treatment
  • 相关文献

参考文献39

  • 1Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) inducedavascular necrosis of the jaws: a growing epidemic [J]. J OralMaxillofac Surg, 2003, 61(9): 1115-1117.
  • 2Advisory Task Force on Bisphosphonate -Related Ostenonecrosisof the Jaws, American Association of Oral and MaxillofacialSurgeons. American Association of Oral and MaxillofacialSurgeons position paper on bisphosphonate -related osteonecrosisof the jaws[J]. J Oral Maxillofac Surg, 2007, 65(3): 369-376.
  • 3British Dental Association. Bisphosphonates fact file [OL].London: British Dental Association, 2008. http://www.bda.org.2008.11.27.
  • 4Khan AA, Sdndor GK, Dore E, et al. Canadian consensuspractice guidelines for bisphosphonate associated osteonecrosis ofthe jaw[J]. J Rheumatol, 2008,35(7): 1391-1397.
  • 5Tubiana-Hulin M, Spielmann M,Roux C, et al. Physiopathologyand management of osteonecrosis of the jaws related tobisphosphonate therapy for malignant bone lesions. A Frenchexpert panel analysis [J]. Crit Rev Oncol Hematol, 2009,71(1):12-21.
  • 6Yoneda T, Hagino H, Sugimoto T, et al. Bisphosphonate -relatedosteonecrosis of the jaw: position paper from the Allied TaskForce Committee of Japanese Society for Bone and MineralResearch, Japan Osteoporosis Society, Japanese Society ofPeriodontology, Japanese Society for Oral and MaxillofacialRadiology, and Japanese Society of Oral and MaxillofacialSurgeons[J]. J Bone Miner Metab, 2010,28(4): 365-383.
  • 7Ruggiero SL, Dodson TB, Assael LA, et al. American Associationof Oral and Maxillofacial Surgeons position paper on bisphospho-nate—related osteonecrosis of the jaws -2009 update [J]. J OralMaxillofac Surg, 2009, 67(5 Suppl): 2-12.
  • 8Allen MR, Burr DB. The pathogenesis of bisphosphonate-relatedosteonecrosis of the jaw: so many hypotheses, so few data [J]. JOral Maxillofac Surg, 2009, 67(5 Suppl): 61-70.
  • 9McMahon RE, Bouquot JE, Glueck CJ, et al. Stagingbisphosphonate -related osteonecrosis of the jaw should includeearly stages of disease [J]. J Oral Maxillofac Surg, 2007,65(9):1899-1990.
  • 10Kwon YD, Kim DY, Ohe JY, et al. Correlation between serum C-terminal cross-linking telopeptide of type I collagen and stagingof oral bisphosphonate-related osteonecrosis of the jaws[J]. J OralMaxillofac Surg, 2009, 67(12): 2644-2648.

二级参考文献53

  • 1阮敏,季彤,张陈平.双膦酸盐性颌骨坏死的研究进展[J].上海口腔医学,2006,15(6):663-667. 被引量:6
  • 2Marx RE. Pamidronate ( Aredia ) and zoledronate ( Zometa ) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg, 2003, 61 : 1115-1118.
  • 3Luckman SP, Hughes DE, Coxon FP, et al. Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post- translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res, 1998 ; 13 : 581-589.
  • 4Woo SB, Hellstein JW, Kalmar JR, et al. Systematic review : bisphosphonates and osteonecrosis of the jaws. Ann Intern Med, 2006,144:753-761.
  • 5Marx RE, Sawatari Y, Fortin M, et al. Bisphosphonate-induced exposed bone (Osteonecrosis/Osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J Oral Maxillofac Surg,2005 ,63 :1567-1575.
  • 6Torsten H, Martin K, Achim W, et al. Osteonecresis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med, 2006, 35: 155-160.
  • 7King AE, Umland EM. Osteoneerosis of the jaw in patients receiving intravenous or oral bisphosphonates. Pharmacotherapy, 2008,28:667-677.
  • 8Badros A, Weikel D, Salama A, et al. Osteonecrosis of the jaw in multiple myeloma patients: clinical features and risk factors. J Clin Oncol,2006, 24:945-952.
  • 9Allen M, Burr D. Mandible matrix necrosis in beagle dogs following 3 years of daily oral bisphosphonate treatment[J]. J Oral Maxillofac Surg, 2008, 66:987-994.
  • 10Landesberg R, Cozin M, Cremers S, et al. Inhibition of oral mucosal cell wound healing by bisphosphonates [J].J Oral Maxillofac Surg, 2008, 66:839-847.

共引文献21

同被引文献133

  • 1孙明霞,赵玉亮,林蓉燕,王晓云,金瑢.帕米膦酸二钠治疗骨转移癌致上颌骨坏死一例[J].中国肿瘤临床与康复,2006,13(2). 被引量:3
  • 2阮敏,季彤,张陈平.双膦酸盐性颌骨坏死的研究进展[J].上海口腔医学,2006,15(6):663-667. 被引量:6
  • 3牟健雄,沈彬.二磷酸盐骨科临床应用的研究进展[J].中国矫形外科杂志,2007,15(1):42-45. 被引量:4
  • 4吴宁,葛才荣.双膦酸盐类药物的临床应用进展[J].中国误诊学杂志,2007,7(16):3707-3709. 被引量:6
  • 5陈银巧(综述),金洁(审校).二膦酸盐相关性颌骨坏死[J].国际输血及血液学杂志,2007,30(4):332-334. 被引量:1
  • 6Marx RE. Pamidronate(Aredia) and zo|edronate(Zometa) induced avascular necrosis of the jaws: a growing epidemic[J]. J Oral Maxillofac Surg, 2003, 61 (9): 1115- 1117.
  • 7Hinson AM, Smith CW, Siegel ER, et al. Is bisphosphonate- related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary[J]. Int J Dent, 2014, 2014: 452737.
  • 8Lumerman HS. Exposed bone in bisphosphonate-related osteonecrosis of the jaws may be induced and maintained by localized microbial biofilm osteomyelitis[J]. J Oral Maxillofac Surg, 2013, 71( 12): 2011.
  • 9Advisory Task Force on Bisphosphonate-Related Ostenonecrosis of the Jaws, American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws[J]. J Oral Maxillofac Surg, 2007, 65(3): 369-376.
  • 10Zaman MU, Nakamoto T, Tanimoto K. A retrospective study of digital subtraction technique to detect sclerotic changes in alveolar bone on intraoral radiographs of bisphosphonate-treated patients[J]. Dentomaxillofac Radiol, 2013, 42 (10): 20130242.

引证文献7

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部